Ying Wang1, Marilyn Sango-Jordan2, Michele Caggana3. 1. 1] Division of Data Management and Research, Office of Primary Care and Health Management System, New York State Department of Health, Albany, New York, USA [2] School of Public Health, University at Albany, State University of New York, Albany, New York, USA. 2. Bureau of Healthcare-Associated Infections, New York State Department of Health, Albany, New York, USA. 3. 1] School of Public Health, University at Albany, State University of New York, Albany, New York, USA [2] Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Abstract
BACKGROUND: Currently, very few studies on long-term follow up of health outcomes and health-care utilization of children with inherited metabolic disorders identified through newborn screening are available. In this project, we analyzed acute care utilization for children with inherited metabolic disorders. METHODS: A cohort of children up to 3 years of age who were born to New York State residents in 2006-2007 with confirmed inherited metabolic disorders identified through newborn screening, was linked to hospital discharge records. For children with multiple acute care encounters (emergency department visits and/or hospital inpatient stays), rehospitalization intervals were quantified as days between a discharge date and the next encounter. RESULTS: Inherited metabolic disorder-related hospital care encounters were more frequent for non-Hispanic black children, Medicaid recipients, and children of younger mothers. A majority (~73%) of the children without health insurance had inherited metabolic disorder-related emergency department visits. Children with private insurance were more likely to have hospital stays. Hospital acute care utilization patterns differed with respect to inherited metabolic disorder category. Children with fatty acid oxidation disorder or organic acid disorders required the most care. CONCLUSIONS: The information collected by the unique population-based surveillance program about hospital care utilization for the affected children can be helpful in assessing health outcomes of the children, identifying at-risk populations, and improving access to essential medical services for children in need.
BACKGROUND: Currently, very few studies on long-term follow up of health outcomes and health-care utilization of children with inherited metabolic disorders identified through newborn screening are available. In this project, we analyzed acute care utilization for children with inherited metabolic disorders. METHODS: A cohort of children up to 3 years of age who were born to New York State residents in 2006-2007 with confirmed inherited metabolic disorders identified through newborn screening, was linked to hospital discharge records. For children with multiple acute care encounters (emergency department visits and/or hospital inpatient stays), rehospitalization intervals were quantified as days between a discharge date and the next encounter. RESULTS: Inherited metabolic disorder-related hospital care encounters were more frequent for non-Hispanic black children, Medicaid recipients, and children of younger mothers. A majority (~73%) of the children without health insurance had inherited metabolic disorder-related emergency department visits. Children with private insurance were more likely to have hospital stays. Hospital acute care utilization patterns differed with respect to inherited metabolic disorder category. Children with fatty acid oxidation disorder or organic acid disorders required the most care. CONCLUSIONS: The information collected by the unique population-based surveillance program about hospital care utilization for the affected children can be helpful in assessing health outcomes of the children, identifying at-risk populations, and improving access to essential medical services for children in need.
Authors: Melanie B Gillingham; Stephen B Heitner; Julie Martin; Sarah Rose; Amy Goldstein; Areeg Hassan El-Gharbawy; Stephanie Deward; Michael R Lasarev; Jim Pollaro; James P DeLany; Luke J Burchill; Bret Goodpaster; James Shoemaker; Dietrich Matern; Cary O Harding; Jerry Vockley Journal: J Inherit Metab Dis Date: 2017-09-04 Impact factor: 4.982
Authors: Ying Wang; Gang Liu; Michele Caggana; Joseph Kennedy; Regina Zimmerman; Suzette O Oyeku; Ellen M Werner; Althea M Grant; Nancy S Green; Scott D Grosse Journal: Genet Med Date: 2014-09-25 Impact factor: 8.822
Authors: Maria D Karaceper; Sara D Khangura; Kumanan Wilson; Doug Coyle; Marni Brownell; Christine Davies; Linda Dodds; Annette Feigenbaum; Deshayne B Fell; Scott D Grosse; Astrid Guttmann; Steven Hawken; Robin Z Hayeems; Jonathan B Kronick; Anne-Marie Laberge; Julian Little; Aizeddin Mhanni; John J Mitchell; Meranda Nakhla; Murray Potter; Chitra Prasad; Cheryl Rockman-Greenberg; Rebecca Sparkes; Sylvia Stockler; Keiko Ueda; Hilary Vallance; Brenda J Wilson; Pranesh Chakraborty; Beth K Potter Journal: Orphanet J Rare Dis Date: 2019-03-22 Impact factor: 4.123
Authors: Alessandro Rossi; Irene J Hoogeveen; Charlotte M A Lubout; Foekje de Boer; Marieke J Fokkert-Wilts; Iris L Rodenburg; Esther van Dam; Sarah C Grünert; Diego Martinelli; Maurizio Scarpa; Hanka Dekker; Sebastiaan T Te Boekhorst; Francjan J van Spronsen; Terry G J Derks Journal: J Inherit Metab Dis Date: 2021-05-04 Impact factor: 4.982
Authors: Andrea J Chow; Michael Pugliese; Laure A Tessier; Pranesh Chakraborty; Ryan Iverson; Doug Coyle; Jonathan B Kronick; Kumanan Wilson; Robin Hayeems; Walla Al-Hertani; Michal Inbar-Feigenberg; Shailly Jain-Ghai; Anne-Marie Laberge; Julian Little; John J Mitchell; Chitra Prasad; Komudi Siriwardena; Rebecca Sparkes; Kathy N Speechley; Sylvia Stockler; Yannis Trakadis; Jagdeep S Walia; Brenda J Wilson; Beth K Potter Journal: Patient Date: 2021-07-20 Impact factor: 3.883